Drugs

, Volume 63, Issue 5, pp 523–524 | Cite as

Imatinib Mesylate

A Viewpoint by Allan van Oosterom
  • Allan van Oosterom
Adis Drug Profile Guest Commentary

Copyright information

© Adis International Limited 2003

Authors and Affiliations

  • Allan van Oosterom
    • 1
  1. 1.Department of Clinical OncologyLeuven University HospitalLeuvenBelgium

Personalised recommendations